Important Notice Regarding Inveltys

Posted in Latest News on February 11, 2019.

During the February 8, 2019 Board of Optometry meeting, the board approved Inveltys (loteprednol etabonate ophthalmic suspension) 1% for addition to Rule 64B13-18.002, F.A.C. Formulary of Topical Ocular Pharmaceutical Agents.

Important note: At this time, Inveltys cannot be prescribed by certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided on the board website and Inveltys may be prescribed by certified optometrists at that time.



More Latest News

First Quarter Performance Report
November 30, 2021

Released for the
2021 – 2022 Fiscal Year Continue reading


The Annual Report and Long-Range Plan Released for Fiscal Year 2020-21
November 1, 2021

The Annual Report and Long-Range Plan for Fiscal Year 2020-21
is now online. Continue reading